Actinium Pharmaceuticals (NYSE: ATNM) is focused on developing innovative targeted radioimmunotherapies for the treatment of advanced cancers. Currently Investigating therapies in #AML and #BMT
View Top Employees from Actinium Pharmaceuticals, Inc.Website | http://www.actiniumpharma.com |
Ticker | ATNM |
Revenue | $173000 |
Employees | 63 (63 on RocketReach) |
Founded | 2000 |
Address | 275 Madison Avenue Suite 702, New York, New York 1001, US |
Phone | (646) 677-3875 |
Industry | Biotechnology Research, Pharmaceuticals, Biotechnology, Other Capital Markets/Institutions, Radioimmunotherapy, Healthcare, Science and Engineering, Other Pharmaceuticals and Biotechnology, Acute Myeloid Leukemia, Medical, Hematopoeitic Stem Cell and Bone Marrow Transplant, Health Care, Biopharmaceuticals and ADC's, Pharmaceutical |
Web Rank | 2 Million |
Keywords | Actinium Pharmaceuticals, Actinium Therapeuticals, Actinum Pipeline, Actinium Therapeutics, Sierra Trial Aml Iomab-B |
Competitors | ARCA biopharma, Inc., Affectis Pharmaceuticals, Altor Bioscience Corporation, Atara Biotherapeutics, Celldex Therapeutics |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular Actinium Pharmaceuticals, Inc. employee's phone or email?
The Actinium Pharmaceuticals, Inc. annual revenue was $173000 in 2024.
Steve O'Loughlin is the CFO of Actinium Pharmaceuticals, Inc..
63 people are employed at Actinium Pharmaceuticals, Inc..
Actinium Pharmaceuticals, Inc. is based in New York, New York.
The NAICS codes for Actinium Pharmaceuticals, Inc. are [325, 32541, 32, 3254].
The SIC codes for Actinium Pharmaceuticals, Inc. are [283, 28].